Current Size: 100%
Age-specific survival
Cancer | Years | Method | Sex | Age | Survived | Net survival | 95% lower | 95% upper |
---|---|---|---|---|---|---|---|---|
Myeloid | 2004-2008 | cohort | Both | 45-54 | 1.00 years | 95.9% | 88.4% | 100.0% |
Myeloid | 2004-2008 | cohort | Both | 45-54 | 5.00 years | 88.3% | 76.2% | 100.0% |
Myeloid | 2004-2008 | cohort | Both | 45-54 | 10.00 years | 88.3% | 76.1% | 100.0% |
Myeloid | 2004-2008 | cohort | Both | 55-64 | 1.00 years | 83.7% | 72.8% | 96.2% |
Myeloid | 2004-2008 | cohort | Both | 55-64 | 5.00 years | 74.1% | 60.9% | 90.0% |
Myeloid | 2004-2008 | cohort | Both | 55-64 | 10.00 years | 68.6% | 54.6% | 86.2% |
Myeloid | 2004-2008 | cohort | Both | 65-74 | 1.00 years | 72.1% | 59.2% | 87.7% |
Myeloid | 2004-2008 | cohort | Both | 65-74 | 5.00 years | 51.4% | 36.7% | 71.9% |
Myeloid | 2004-2008 | cohort | Both | 65-74 | 10.00 years | 11.0% | 2.6% | 47.0% |
Myeloid | 2004-2008 | cohort | Both | 75-99 | 1.00 years | 61.9% | 50.8% | 75.5% |
Myeloid | 2004-2008 | cohort | Both | 75-99 | 5.00 years | 30.7% | 18.8% | 50.1% |
Myeloid | 2004-2008 | cohort | Both | 75-99 | 10.00 years | 14.1% | 5.3% | 37.7% |